John Couling - May 15, 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Signature
/s/ Daniel Rodriguez, Attorney-in-Fact for John Couling
Stock symbol
DLB
Transactions as of
May 15, 2023
Transactions value $
-$23,316
Form type
4
Date filed
5/16/2023, 05:12 PM
Previous filing
Feb 8, 2023
Next filing
Nov 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale -$23.3K -278 -0.29% $83.87 96.2K May 15, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest.
F2 Shares include 278 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023.

Remarks:

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 17, 2022, as amended February 6, 2023, which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.